Innovative Eyewear Inc. insider activity: Chief Executive Officer and director Harrison R. Gross reported buying 1,500 shares of Innovative Eyewear common stock on January 21, 2026 at a price of $1.32 per share. Following this purchase, he directly beneficially owns 13,733 common shares.
The filing notes that this transaction created a short-swing profit under Section 16(b) of the Securities Exchange Act of 1934. Gross agreed to voluntarily disgorge $1,036.20, described as the full amount of that profit, to Innovative Eyewear, and this amount was paid in full on January 21, 2026.
Form 144 notice for Innovative Eyewear, Inc. (ticker LUCYW) discloses a proposed sale of 760 common shares through Raymond James on 09/10/2025 on the NASDAQ with an aggregate market value of $1,611.20. The securities were acquired as an RSU grant on 08/19/2025 totaling 7,200 shares with payment in cash recorded on the same date. The filing also lists a prior sale by the reporting person of 2,225 shares on 08/19/2025 generating $4,422.00 in gross proceeds. The notice includes the standard representation that the seller does not possess undisclosed material information.
Innovative Eyewear, Inc. (ticker: LUCYW) Form 144 notice reports a proposed sale of 2,596 common shares valued at an aggregate $5,057.55 to be sold through Raymond James & Associates on 08/19/2025 on NASDAQ. The filer shows the shares were acquired the same day, 08/19/2025, as an RSU grant from the issuer representing 8,400 shares granted, with the reported form indicating cash payment. The filing lists total shares outstanding as 4,574,602. No securities were reported sold by the filer in the prior three months and no additional remarks or plan-adoption dates are provided.
Form 144 notice: A person affiliated with Innovative Eyewear, Inc. (ticker LUCYW) notified a proposed sale of 1,485 common shares through Raymond James on 08/19/2025. The filing lists an aggregate market value of $2,889.95 for the shares and reports 4,574,602 shares outstanding. The securities were acquired the same day as an RSU grant dated 08/19/2025 for 4,800 shares, with cash listed as the payment method. The filer attests they are not aware of any undisclosed material adverse information about the issuer.
Innovative Eyewear, Inc. (LUCYW) Form 144 reports a proposed sale of 3,009 common shares to be executed through Raymond James & Associates on 08/19/2025 on NASDAQ. The filing lists an aggregate market value of $5,894.17 for the shares and states total shares outstanding of 4,574,602, providing the basic size and timing of the planned transaction.
The securities were acquired as an RSU grant on 08/19/2025 (noted amount: 9,600 shares) with cash listed as the payment type. The filer attests by signature that they do not possess undisclosed material adverse information about the issuer.
Form 144 notice for Innovative Eyewear, Inc. (symbol LUCYW) reports a proposed sale of 2,225 common shares through Raymond James on 08/19/2025 with an aggregate market value of $4,421.80. The filing shows the securities were acquired the same day as an RSU grant (8,200 units granted; 7,200 units listed as acquired) and payment is listed as cash. The issuer's outstanding shares are stated as 4,574,602. Several standard filer and issuer contact fields are blank in the submission.
Form 144 notice for Innovative Eyewear, Inc. (ticker LUCYW) shows a proposed sale of 1,670 common shares through Raymond James on 08/19/2025 on NASDAQ with an aggregate market value of $3,317.35. The filing reports the securities were acquired as an RSU grant from the issuer on 08/19/2025, with 5,400 units acquired and payment marked as cash. The issuer’s total shares outstanding are listed as 4,574,602. The filer certifies they are not aware of undisclosed material adverse information and indicates no securities sold in the prior three months.
Innovative Eyewear, Inc. reported that on August 15, 2025 it filed a prospectus supplement to increase the maximum number of shares of its common stock that may be issued under its existing At The Market Offering Agreement with H.C. Wainwright & Co., originally dated April 15, 2024. This update means the company can issue more common shares through that ongoing at-the-market program as needed, rather than in a single large transaction.
The company also filed a legal opinion from Ellenoff Grossman & Schole LLP, attached as Exhibit 5.1, confirming the legality of issuing and selling these shares. A related consent from the same firm is included as Exhibit 23.1.
The company is updating its at-the-market common stock offering to allow sales of up to $2,679,217 of common stock through H.C. Wainwright & Co. under an existing sales agreement and shelf registration. This amount excludes approximately $1,202,269 of common stock already sold under earlier related prospectus supplements. The filing notes a public float of about $11,644,460, based on 3,298,714 shares held by non-affiliates at $3.53 per share as of June 20, 2025. The common stock trades on the Nasdaq Capital Market under the symbol LUCY, with a last reported price of $2.20 per share on August 14, 2025. Investors are directed to detailed risk factor discussions before purchasing shares.
Innovative Eyewear's Schedule 13G/A reports that Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC collectively beneficially own 475,728 shares of common stock, representing approximately 9.99% of the outstanding shares as of June 30, 2025. That total consists of 288,282 shares held by Intracoastal and 187,446 shares issuable upon exercise of Intracoastal Warrant 1. The filing discloses multiple additional warrant tranches excluded from the reported percentage because of blocker provisions, and states that without those blockers the group could be deemed to beneficially own 2,616,499 shares. The reporting persons indicate 0 sole voting power and shared voting and dispositive power over the reported 475,728 shares and certify the holdings were not acquired to change or influence control.